Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa

Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa – New England Journal of Medicine (free)

Related: Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger – New England Journal of Medicine (free)

Related Commentary on Twitter

In this open-label extension study, MORDOR II, the effect on mortality persisted through a third year and was seen in the MORDOR I placebo group that was now treated with azithromycin. Read the abstract: https://t.co/hRIjQSyYhQ

— NEJM (@NEJM) June 5, 2019